NAVCO Pharmaceuticals Inc. (NAV.V)

0.0350 0.0000 (0.00%) At close: 03:54PM EDT

NAVCO Pharmaceuticals Inc.

5205 Harvester Road
Unit 1
Burlington, ON L7L 6B5
Canada
289-430-5190
https://navcopharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Geoffrey Lee	Chief Executive Officer	62.77k	N/A	N/A
Mr. Chris Cooper	Chief Financial Officer	31.6k	N/A	1971
Mr. Marek Jasinski	COO & Director	72k	N/A	1977
Mr. Thomas Jusdanis	Corporate Secretary & Director	55.53k	N/A	1958

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

NAVCO Pharmaceuticals Inc. researches, develops, manufactures, and commercializes nanotechnology products and materials. It offers aerosol spray, hand cream and sanitizer, and colloidal silver products. The company also provides COVID PCR testing, PPE, and diagnostic PCR testing, as well as textile and food solutions. Its products are used in medical, personal care products, textile, chemical, and additive industries. The company is headquartered in Burlington, Canada.

Corporate governance

NAVCO Pharmaceuticals Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.